HIGHLIGHTS OF PRESCRIBING INFORMATION
... • Carbamazepine and other enzyme inducers decrease plasma concentrations of risperidone. (7.11) -----------------------USE IN SPECIFIC POPULATIONS----------------------• Nursing Mothers: should not breast feed. (8.3) • Pediatric Use: safety and effectiveness not established for schizophrenia less ...
... • Carbamazepine and other enzyme inducers decrease plasma concentrations of risperidone. (7.11) -----------------------USE IN SPECIFIC POPULATIONS----------------------• Nursing Mothers: should not breast feed. (8.3) • Pediatric Use: safety and effectiveness not established for schizophrenia less ...
Efficacy of Lasers and PDT for the Treatment of Acne Vulgaris*
... showed that lesion counts decreased by 37% after one treatment, 58% after two treatments and 83% after three treatments. Treatment related side-effects included transient erythema and edema. Topical anesthetics were utilized to minimize the discomfort routinely associated with these laser procedures ...
... showed that lesion counts decreased by 37% after one treatment, 58% after two treatments and 83% after three treatments. Treatment related side-effects included transient erythema and edema. Topical anesthetics were utilized to minimize the discomfort routinely associated with these laser procedures ...
Pharmacogenetic studies of paclitaxel in ovarian cancer pharmacodynamics and
... Ovarian cancer is one of the most common female cancer diseases in the world today and in Sweden more than 800 new cases are diagnosed every year. The standard treatment consists of chemotherapy with paclitaxel in combination with carboplatin after initial cytoreductive surgery. The response to trea ...
... Ovarian cancer is one of the most common female cancer diseases in the world today and in Sweden more than 800 new cases are diagnosed every year. The standard treatment consists of chemotherapy with paclitaxel in combination with carboplatin after initial cytoreductive surgery. The response to trea ...
Extract from the Clinical Evaluation Report for tenofovir disoproxil
... PrEP for at risk subjects in Australia. VicPrEP and QPrEP are on-going pilot clinical trials in at risk subjects sponsored by Monash University, Queensland Department of Health and the HIV Foundation of Queensland, respectively. The TORCH study sponsored by the Kirby Institute, University of New Sou ...
... PrEP for at risk subjects in Australia. VicPrEP and QPrEP are on-going pilot clinical trials in at risk subjects sponsored by Monash University, Queensland Department of Health and the HIV Foundation of Queensland, respectively. The TORCH study sponsored by the Kirby Institute, University of New Sou ...
Adverse Reactions to Radiopharmaceuticals
... (TUFAM) of the Ministry of Health and to the manufacturer. Adverse drug reaction reporting form is available from the Turkish Pharmacovigilance Center (TUFAM) of the Ministry of Health (1). An example of this adverse drug reaction reporting form prepared by a manufacturer can be found at the address ...
... (TUFAM) of the Ministry of Health and to the manufacturer. Adverse drug reaction reporting form is available from the Turkish Pharmacovigilance Center (TUFAM) of the Ministry of Health (1). An example of this adverse drug reaction reporting form prepared by a manufacturer can be found at the address ...
Adenosine
... Repeat administration: If conversion of PSVT does not occur within 1-2 minutes, additional bolus injections of adenosine can be administered at incrementally higher doses, increasing the amount given by 0.05 to 0.1 mg/kg. Follow each bolus with a saline flush. This process should continue until sinu ...
... Repeat administration: If conversion of PSVT does not occur within 1-2 minutes, additional bolus injections of adenosine can be administered at incrementally higher doses, increasing the amount given by 0.05 to 0.1 mg/kg. Follow each bolus with a saline flush. This process should continue until sinu ...
bioequivalence guideline
... vement in the final version published in February 2010. It now offers a more robust set of criteria by which to assess the applications made for generic medicines and increases assurance regarding the acceptance of their applications and reduces the amount of time the authorities need to debate bord ...
... vement in the final version published in February 2010. It now offers a more robust set of criteria by which to assess the applications made for generic medicines and increases assurance regarding the acceptance of their applications and reduces the amount of time the authorities need to debate bord ...
Luxiq - GlaxoSmithKline
... Systemic absorption of topical corticosteroids has produced reversible hypothalamicpituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal from treatment. Manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria can also be produc ...
... Systemic absorption of topical corticosteroids has produced reversible hypothalamicpituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal from treatment. Manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria can also be produc ...
Salmeson Inhalation powder pre
... therefore, that the patient is reviewed regularly and the dose of inhaled corticosteroid is reduced to the lowest dose at which effective control of asthma is maintained. Prolonged treatment of patients with high doses of inhaled corticosteroids may result in adrenal suppression and acute adrenal cr ...
... therefore, that the patient is reviewed regularly and the dose of inhaled corticosteroid is reduced to the lowest dose at which effective control of asthma is maintained. Prolonged treatment of patients with high doses of inhaled corticosteroids may result in adrenal suppression and acute adrenal cr ...
Artemisia annua(Sweet Annie), Other Artemisia Species, Artemisinin
... enormous quantities of seeds. The part used therapeutically is the flowering top. A. annua has many chemotypes and cultivars with varying chemistries that can significantly affect medicinal activity.3 The high-artemisinin cultivars that dominate in China and Africa develop peak artemisinin levels be ...
... enormous quantities of seeds. The part used therapeutically is the flowering top. A. annua has many chemotypes and cultivars with varying chemistries that can significantly affect medicinal activity.3 The high-artemisinin cultivars that dominate in China and Africa develop peak artemisinin levels be ...
Asian-Pacific consensus statement on the management of chronic
... decompensation, and HCC [19]. Large studies in asymptomatic HBsAg carriers have also demonstrated that frequent ALT elevation during long-term follow-up is a factor for the development of cirrhosis and HCC [20, 21]. HCC develops at an annual incidence of 3–6 % in patients with cirrhosis and far less ...
... decompensation, and HCC [19]. Large studies in asymptomatic HBsAg carriers have also demonstrated that frequent ALT elevation during long-term follow-up is a factor for the development of cirrhosis and HCC [20, 21]. HCC develops at an annual incidence of 3–6 % in patients with cirrhosis and far less ...
POTASSIUM SUPPLEMENTS (parenteral) - DavisPlus
... should be corrected to facilitate effectiveness of potassium replacement. Monitor serum chloride because hypochloremia may occur if replacing potassium without concurrent chloride. ● Toxicity and Overdose: Symptoms of toxicity are those of hyperkalemia (slow, irregular heartbeat; fatigue; muscle wea ...
... should be corrected to facilitate effectiveness of potassium replacement. Monitor serum chloride because hypochloremia may occur if replacing potassium without concurrent chloride. ● Toxicity and Overdose: Symptoms of toxicity are those of hyperkalemia (slow, irregular heartbeat; fatigue; muscle wea ...
lipidil supra pm
... rhabdomyolysis, usually in patients with impaired renal function and in cases of hypoalbuminaemia. Myopathy should be considered in any patient with diffuse myalgias, myositis, muscle cramps, tenderness or weakness, and/or marked elevation of creatine phosphokinase levels. Patients should be advised ...
... rhabdomyolysis, usually in patients with impaired renal function and in cases of hypoalbuminaemia. Myopathy should be considered in any patient with diffuse myalgias, myositis, muscle cramps, tenderness or weakness, and/or marked elevation of creatine phosphokinase levels. Patients should be advised ...
Review of cough and cold medicines in children
... definite diagnosis, and for cough and other symptoms believed by a parent to be due to the common cold. The brief discussion to follow refers to causes of these symptoms and to symptom patterns associated with common respiratory illnesses in childhood. This is relevant to the question – does it matt ...
... definite diagnosis, and for cough and other symptoms believed by a parent to be due to the common cold. The brief discussion to follow refers to causes of these symptoms and to symptom patterns associated with common respiratory illnesses in childhood. This is relevant to the question – does it matt ...
problem amphetamine and methamphetamine use in
... containing pseudoephedrine (those with up to 30 mg per tablet) to a maximum monthly dose of 1 800 mg of pseudoephedrine (i.e. 60 tablets, 30 mg each) per person. Mail order sales were banned, and supply would be monitored via the central database of electronic prescriptions. In November 2009, the ma ...
... containing pseudoephedrine (those with up to 30 mg per tablet) to a maximum monthly dose of 1 800 mg of pseudoephedrine (i.e. 60 tablets, 30 mg each) per person. Mail order sales were banned, and supply would be monitored via the central database of electronic prescriptions. In November 2009, the ma ...
LSEHWP39
... affects men and women equally, there are many gender-specific health issues in epilepsy (Kobau et al, 2008). Issues unique to women include choice of AED in women of childbearing age, teratogenicity, breastfeeding, hormonal influences on seizures and contraceptive drug interactions (Pennell and Thom ...
... affects men and women equally, there are many gender-specific health issues in epilepsy (Kobau et al, 2008). Issues unique to women include choice of AED in women of childbearing age, teratogenicity, breastfeeding, hormonal influences on seizures and contraceptive drug interactions (Pennell and Thom ...
Risperdal/Risperdal M-Tab/ Risperdal Consta (risperidone)
... At lower dosages, Risperdal is generally well tolerated. Common side effects include sedation, dizziness, headache, nausea, vomiting, constipation, insomnia, and agitation. There is a higher incidence of extrapyramidal symptoms (EPS) when the dosage of Risperdal exceeds 6 mg/day. EPS are neurologica ...
... At lower dosages, Risperdal is generally well tolerated. Common side effects include sedation, dizziness, headache, nausea, vomiting, constipation, insomnia, and agitation. There is a higher incidence of extrapyramidal symptoms (EPS) when the dosage of Risperdal exceeds 6 mg/day. EPS are neurologica ...
1.1. Tamsulosin and visual disturbances Introduction
... Patient M only has vision in one eye, vision is normally 5-15%. He has been using atropine eyedrops since 1946 to increase his pupil. Ten years prior to the present reaction, the patient also used tamsulosin and at that time also suffered from abnormal vision. Other sources of information SmPC In th ...
... Patient M only has vision in one eye, vision is normally 5-15%. He has been using atropine eyedrops since 1946 to increase his pupil. Ten years prior to the present reaction, the patient also used tamsulosin and at that time also suffered from abnormal vision. Other sources of information SmPC In th ...
Text
... liposomes prolonged lidocaine anesthesia compared with a conventional cream with a higher deposition in the epidermis and dermis being recorded [27]. The improved anesthetic effect after vesicular delivery could be thus attributed to improved skin accumulation. In another report, liposomal tetracain ...
... liposomes prolonged lidocaine anesthesia compared with a conventional cream with a higher deposition in the epidermis and dermis being recorded [27]. The improved anesthetic effect after vesicular delivery could be thus attributed to improved skin accumulation. In another report, liposomal tetracain ...
Dept. of Quality Assurance
... widely used technique called swab testing. Clean wet, swabs are applied to areas that have been cleaned and an extract of that swab is analyzed to show the effectiveness of that cleaning. Swab testing, however, is expensive and time consuming, but sampling does not represent the entire part of equip ...
... widely used technique called swab testing. Clean wet, swabs are applied to areas that have been cleaned and an extract of that swab is analyzed to show the effectiveness of that cleaning. Swab testing, however, is expensive and time consuming, but sampling does not represent the entire part of equip ...
Clindamycin in 0.9% Sodium Chloride Injection
... with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate [see Indications and Usage (1)]. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections. C. difficil ...
... with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate [see Indications and Usage (1)]. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections. C. difficil ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
... Based on bioequivalence data, patients taking divided doses of immediate-release ADDERALL, (for example, twice daily), may be switched to ADDERALL XR at the same total daily dose taken once daily. Titrate at weekly intervals to appropriate efficacy and tolerability as indicated. ADDERALL XR capsules ...
... Based on bioequivalence data, patients taking divided doses of immediate-release ADDERALL, (for example, twice daily), may be switched to ADDERALL XR at the same total daily dose taken once daily. Titrate at weekly intervals to appropriate efficacy and tolerability as indicated. ADDERALL XR capsules ...
Promus PREMIER ™
... determine the safety and effectiveness of the 2.25 mm diameter stent (Small Vessel sub-study), and the 32 and 38 mm lengths (Long Lesion sub-study). The Small Vessel sub-study included 94 patients with a planned five-year clinical follow-up. The study results showed that patients who received a PROM ...
... determine the safety and effectiveness of the 2.25 mm diameter stent (Small Vessel sub-study), and the 32 and 38 mm lengths (Long Lesion sub-study). The Small Vessel sub-study included 94 patients with a planned five-year clinical follow-up. The study results showed that patients who received a PROM ...
The Essential Medicinal Chemistry of Curcumin
... vitro), even though this testing may have been bedeviled by design problems that led to several misfires. The structure of 1 suggests that it might be unstable in a biological setting, and in fact, it is: both its in vitro and in vivo stabilities are abysmal (T1/2 < 5 min; F < 1%)27,28 relative to co ...
... vitro), even though this testing may have been bedeviled by design problems that led to several misfires. The structure of 1 suggests that it might be unstable in a biological setting, and in fact, it is: both its in vitro and in vivo stabilities are abysmal (T1/2 < 5 min; F < 1%)27,28 relative to co ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.